⌘K

Login Start Free

Home/Filings/4/0001192482-21-000042

4//SEC Filing

HENWOOD GERALDINE 4

Accession 0001192482-21-000042

CIK 0001588972other

View on SEC.gov Company Profile

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 5:04 PM ET

Size

5.1 KB

Accession

0001192482-21-000042

Insider Transaction Report

Form 4

Period: 2021-01-02

Recro Pharma, Inc.REPH

HENWOOD GERALDINE

DirectorPresident and CEO

Transactions

Tax Payment
Common Stock
2021-01-02$3.09/sh−5,599$17,301→ 201,467 total

Holdings

Common Stock
(indirect: By Spouse)
50,000

Footnotes (1)

[F1]Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Documents

1 file

4
edgar.xmlPrimary
PRIMARY DOCUMENT

Issuer

Recro Pharma, Inc.

CIK 0001588972

Entity typeother

Related Parties

1

filerCIK 0001236451

Filing Metadata

Form type: 4
Filed: Jan 4, 7:00 PM ET
Accepted: Jan 5, 5:04 PM ET
Size: 5.1 KB

View on SEC.gov